PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

ABSTRACT: A Phase 1 dose escalation and expansion study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors.

DISEASE(S): Adenocarcinoma,Melanoma,Mesothelioma,Prostate Neoplasms,Liver Neoplasms,Breast Neoplasms,Breast Cancer,Neoplasms,Neoplasms, Squamous Cell,Prostatic Neoplasms,Carcinoma, Renal Cell,Colorectal Neoplasms,Prostate Cancer,Pancreatic Neoplasms

PROVIDER: 2285250 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR